201 related articles for article (PubMed ID: 15338791)
1. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.
van der Woude HJ; Postma DS; Politiek MJ; Winter TH; Aalbers R
Respir Med; 2004 Sep; 98(9):816-20. PubMed ID: 15338791
[TBL] [Abstract][Full Text] [Related]
2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
3. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction.
Politiek MJ; Boorsma M; Aalbers R
Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394
[TBL] [Abstract][Full Text] [Related]
4. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
[TBL] [Abstract][Full Text] [Related]
5. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
6. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.
van der Woude HJ; Aalbers R
Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283
[TBL] [Abstract][Full Text] [Related]
7. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
[TBL] [Abstract][Full Text] [Related]
8. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
Richter K; Janicki S; Jörres RA; Magnussen H
Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
[TBL] [Abstract][Full Text] [Related]
9. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
Lipworth BJ; Aziz I
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
[TBL] [Abstract][Full Text] [Related]
10. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
12. Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma.
Pohunek P; Matulka M; Rybnícek O; Kopriva F; Honomichlová H; Svobodová T
Pediatr Allergy Immunol; 2004 Feb; 15(1):32-9. PubMed ID: 14998380
[TBL] [Abstract][Full Text] [Related]
13. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[TBL] [Abstract][Full Text] [Related]
14. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
15. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction.
Boulet LP; Turcotte H; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
Chest; 1998 Aug; 114(2):373-9. PubMed ID: 9726717
[TBL] [Abstract][Full Text] [Related]
16. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action.
van Noord JA; Smeets JJ; Raaijmakers JA; Bommer AM; Maesen FP
Eur Respir J; 1996 Aug; 9(8):1684-8. PubMed ID: 8866595
[TBL] [Abstract][Full Text] [Related]
18. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
20. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.
Seberová E; Andersson A
Respir Med; 2000 Jun; 94(6):607-11. PubMed ID: 10921767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]